{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:26:07Z","timestamp":1788279967681,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18ek0510023h0002"],"award-info":[{"award-number":["18ek0510023h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jtct.2024.11.011","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:09:57Z","timestamp":1732604997000},"page":"103.e1-103.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-7550","authenticated-orcid":false,"given":"Kaito","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-230X","authenticated-orcid":false,"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-0823","authenticated-orcid":false,"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Jinguji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-6083","authenticated-orcid":false,"given":"Fumihiko","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jtct.2024.11.011_bib0001","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2024.11.011_bib0002","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jamaoncol.2019.3541","article-title":"Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a systematic review and meta-analysis: a systematic review and meta-analysis","volume":"5","author":"Gagelmann","year":"2019","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.011_bib0003","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41409-018-0279-1","article-title":"Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide","volume":"54","author":"Sugita","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2024.11.011_bib0004","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2015.06.008","article-title":"HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning","volume":"21","author":"Sugita","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.11.011_bib0005","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/TP.0000000000004006","article-title":"Single cord blood transplantation versus HLA-haploidentical-related donor transplantation using posttransplant cyclophosphamide in patients with hematological malignancies","volume":"106","author":"Wada","year":"2022","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.jtct.2024.11.011_bib0006","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41409-022-01770-y","article-title":"Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation","volume":"57","author":"Sugita","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2024.11.011_bib0007","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/bjh.19372","article-title":"First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia","volume":"204","author":"Jo","year":"2024","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jtct.2024.11.011_bib0008","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbmt.2019.10.014","article-title":"Prospective randomized study comparing myeloablative unrelated umbilical cord blood transplantation versus HLA-haploidentical related stem cell transplantation for adults with hematologic malignancies","volume":"26","author":"Sanz","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2024.11.011_bib0009","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2015.98","article-title":"Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia","volume":"29","author":"Ruggeri","year":"2015","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.jtct.2024.11.011_bib0010","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/bloodadvances.2021004462","article-title":"Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning","volume":"5","author":"Wagner","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2024.11.011_bib0011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2024.11.011_bib0012","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.jtct.2022.07.006","volume":"28","author":"Ruggeri","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.011_bib0013","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jtct.2024.11.011_bib0014","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1200\/JCO.19.02408","article-title":"Nonmyeloablative alternative donor transplantation for Hodgkin and non-Hodgkin lymphoma: from the LWP-EBMT, Eurocord, and CIBMTR","volume":"38","author":"Fatobene","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2024.11.011_bib0015","doi-asserted-by":"crossref","first-page":"109.e1","DOI":"10.1016\/j.jtct.2021.11.002","article-title":"Umbilical cord blood or HLA-haploidentical transplantation: real-world outcomes versus randomized trial outcomes","volume":"28","author":"O'Donnell","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.011_bib0016","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbmt.2018.08.026","article-title":"HLA-mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis","volume":"25","author":"Robin","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.011_bib0017","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-018-0655-8","article-title":"Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine","volume":"11","author":"Giannotti","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.011_bib0018","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"6","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.jtct.2024.11.011_bib0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2024.11.011_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.25705","article-title":"Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017","volume":"95","author":"Konuma","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.011_bib0021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjh.15418","article-title":"Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?","volume":"185","author":"Nakasone","year":"2019","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.011_bib0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2024.11.011_bib0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"issue":"11","key":"10.1016\/j.jtct.2024.11.011_bib0024","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41409-019-0539-8","article-title":"Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience","volume":"54","author":"Yanada","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2024.11.011_bib0025","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3324\/haematol.2012.076042","article-title":"Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia","volume":"98","author":"Atsuta","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2024.11.011_bib0026","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.011_bib0027","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.jtct.2024.11.011_bib0028","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2024.11.011_bib0029","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41409-021-01310-0","article-title":"Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation","volume":"56","author":"Harada","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.11.011_bib0030","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.011_bib0031","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.011_bib0032","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR'for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.011_bib0033","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.13802","article-title":"Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols","volume":"172","author":"Hough","year":"2016","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2024.11.011_bib0034","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bbmt.2016.06.012","article-title":"Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation","volume":"22","author":"Ballen","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.11.011_bib0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","article-title":"Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation","volume":"16","author":"Beck","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2024.11.011_bib0036","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbmt.2015.02.017","article-title":"General and virus-specific immune cell reconstitution after double cord blood transplantation","volume":"21","author":"Saliba","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.011_bib0037","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2017014464","article-title":"Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD","volume":"2","author":"Bejanyan","year":"2018","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2024.11.011_bib0038","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","article-title":"Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts","volume":"20","author":"Raiola","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2024.11.011_bib0039","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jtct.2021.07.023","article-title":"Increased infections and delayed CD4+ T cell but faster B cell immune reconstitution after post-transplantation cyclophosphamide compared to conventional GVHD prophylaxis in allogeneic transplantation","volume":"27","author":"Khimani","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2015.76","article-title":"Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know","volume":"50","author":"Ogata","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10.1016\/j.jtct.2024.11.011_bib0041","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/bloodadvances.2022009274","article-title":"Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients","volume":"7","author":"Noviello","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.11.011_bib0042","article-title":"Clinical significance of haplo-fever and cytokine profiling after graft infusion in allogeneic stem cell transplantation from haplo-identical donors","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.jtct.2024.11.011_bib0043","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.11.011_bib0044","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2019.06.010","article-title":"Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells","volume":"207","author":"Karantanos","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtct.2024.11.011_bib0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2016.07.030","article-title":"Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis","volume":"100","author":"Matz","year":"2017","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.jtct.2024.11.011_bib0046","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bbmt.2013.05.003","article-title":"Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation","volume":"19","author":"Murata","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2024.11.011_bib0047","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2024.11.011_bib0048","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/leu.2016.288","article-title":"Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation","volume":"31","author":"Kanda","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jtct.2024.11.011_bib0049","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.jtct.2023.03.001","article-title":"Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia","volume":"29","author":"Konuma","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2024.11.011_bib0050","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bbmt.2019.02.007","article-title":"Development of pre-engraftment syndrome, but not acute graft-versus-host disease, reduces relapse rate of acute myelogenous leukemia after single cord blood transplantation","volume":"25","author":"Isobe","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724007826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724007826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T09:31:01Z","timestamp":1738575061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724007826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2666636724007826"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.11.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Nonrelapse Mortality After Haploidentical Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation in Hematologic Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}